Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms

Introduction Androgen deprivation therapy (ADT) is a key treatment modality in the management of prostate cancer (PCa), especially for patients with metastatic disease. Increasing evidences suggest that patients who received ADT have increased incidence of diabetes, myocardial infarction, stroke, an...

Ausführliche Beschreibung